CMS’ McClellan To Discuss Medicare Rx With AARP Board Feb. 1
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency chief will address the organization’s annual policy meeting less than two weeks after release of the final rules implementing Part D drug benefit. HHS Information Technology Coordinator Brailer is expected to discuss the e-prescribing draft rule.
You may also be interested in...
E-Prescribing Draft Rule Proposes Adoption Of Formulary Info Standards
The proposal would establish standards for delivering formulary information based on an RxHub protocol. Under the rule, formulary transmissions would include information on coverage, preferred alternative drugs and comparative copayments.
Medicare Rx Final Regs Retain CMS Right To Plans’ Drug Price Information
Agency releases final rules implementing Title I and II of the Medicare Modernization Act. CMS’ authority to evaluate data on drug prices negotiated by Medicare prescription drug plans does not violate the “non-interference” provision of MMA, reg states. Drug price reviews will be “rare,” CMS says.
House Appropriations Subcommittee Plans FDA Hearing July 26
Ag/FDA subcommittee had tabled FDA hearing pending confirmation of a permanent agency commissioner. House cleared FDA 2006 spending in early June.